Dr. Bruce E. Maryanoff, BS, College of Arts and Sciences, Chemistry, 1969; PhD, Chemistry, 1972. Former Distinguished Research Fellow, Johnson & Johnson Pharmaceutical Research & Development
Dr. Bruce E. Maryanoff was a Distinguished Research Fellow at Johnson & Johnson Pharmaceutical Research & Development. He retired in 2009 after 36 years of service and is now active with The Scripps Research Institute, LaJolla, California, and the Pennsylvania Drug Discovery Institute, Doylestown, PA. Dr. Maryanoff has been the recipient of major awards from the American Chemical Society (ACS) for his research in 2000, 2003 and 2009, and he has won Johnson & Johnson's Philip B. Hoffman Research Scientist award twice. He is the inventor of topiramate, a novel anti-epileptic drug, for which he received the prestigious Johnson Medal from Johnson & Johnson. He holds 70 United States patents and has 270 scientific publications to his credit, including the multi-volume Advances in Medicinal Chemistry, co-edited with his wife, Cynthia Maryanoff, PhD. Dr. Maryanoff is a member of a number of chemical societies and was elected Fellow of the American Association for the Advancement of Science (AAAS), the ACS, and the Royal Society of Chemistry. Dr. Maryanoff is a member of Drexel's College of Arts and Sciences Advisory Board, and he established with his wife the Bruce and Cynthia Maryanoff Endowed Chemistry Prize. He is a recipient of a Distinguished Alumnus Award for Drexel and, in 2002, was inducted into the National Commission for Cooperative Education Hall of Fame.
April 2011
Bruce Maryanoff '69, '72